Location, Location, Location: Two Key CP86 Questions Clarified (Kind Of!)

December 21, 2020
We delve into two of the key frequently asked questions from the “Dear Chair” CP86 letter that were raised across the industry.

2020 has been a year like no other. One contradictory aspect of this year’s enforced lockdown is that some days have seemed long, drawn out, almost never ending, while at the same time weeks, months, and indeed the year has simply flown by! For me, anyway. In similarly contradictory fashion, for six years now in Ireland, Consultation Paper 86 (CP86) like a badly calibrated pendulum, has swung between being viewed as critically important to being an incidental afterthought, from being urgent and imperative to a marginalized lower priority, all depending on who you ask.

What’s more certain however, is we appear to be at end game for Irish Fund Management Companies (FMCs) caught by CP86. As most readers will already know, on October 20th the Central Bank of Ireland (CBI) published a “Dear Chair” letter outlining findings of the CBI’s thematic review of the CP86 framework. The letter is the result of an 18-month review of all 358 active FMCs in Ireland.

The “Dear Chair” letter points out several areas in need of improvement, including more challenge of fund delegates by designated persons, better quality of reporting, board composition, time commitments, and succession planning. Within the letter, the CBI demand that FMCs “critically assess their position” against the letter’s findings and prepare a board-approved action plan by the end of March 2021. The action plan ensures compliance with the recast parameters of the CP86 framework, with a timeline agreed for the action plans’ execution. The CBI will conduct an industry-wide review of these matters in 2022 “to assess firms’ actions on foot of these findings”. As such, the industry is mobilizing already to ensure compliance. 

While the letter is clear on most issues, there were two questions raised uniformly across the industry as it digested its contents, which the Central Bank have subsequently responded to:

1. Do the CBI’s prescribed minimum three full-time employees (FTE) apply to Self-Managed Investment Companies (SMICs)?

Here, the CBI is unequivocal and confirms the 3 FTE requirement is a minimum requirement, applying to all FMCs, including SMICs (as well as internally managed alternative investment funds).

2. The letter states that FMCs must appoint locally based Designated Persons who conduct managerial functions including oversight of delegated activities. Does this mean all Designated persons must be based in Ireland?

This question is far more nuanced, and arises primarily because the CBI already prescribes an effective supervision rule through Regulation 104 of the Central Bank UCITS Regulations 2019, colloquially known as the “Location Rule”, which speaks to the CBI’s ability to effectively supervise FMCs, including the physical proximity of FMC directors and designated persons. The letter sets out certain recalibrated expectations which to some, were slightly unclear.    

The CBI’s response provides some specificity to the local resource issue, but also leaves it open ended and somewhat to the FMC’s own discretion to ensure they have the requisite a level of resource to comply with the CP86 requirements. 

The clarification letter states:

For an Irish-authorised firm, the management of the entity must take place in the jurisdiction. It is difficult to see how a fund management company could be considered to be located in Ireland unless a clear and convincing preponderance of the firm’s Designated Persons and management roles (including key roles) are performed within the jurisdiction.



So, the general FTE requirements are crystal clear, so too is the fact that the overall FMC management must clearly be anchored in Ireland. However, the term “clear and convincing preponderance” seems open to interpretation, and in its interpretation, perhaps lies some positive news. As set out, it appears to allow for the continued use of designated persons and support resources outside of Ireland. This is particularly true if this non-Irish resource can convince the bank that they are either exclusively or primarily dedicated to functions which support the Irish FMC. This is the case for many global asset managers who have staff in London, New York or other locations, who spend much of their time dedicated to oversight of their Irish UCITS funds product.  

The exact acceptable proportion of what is conducted within the jurisdiction and outside remains unclear (or unsaid to be more precise) and may only become evident as FMCs and CBI ultimately discuss their CP86 action plans. However, overall, this is a very significant and possibly positive clarification, as it removes the specter of an expectation that all DP functions and support resources having to exclusively reside in Ireland. This is an area which will certainly be fleshed out as FMC, their advisors, and the CBI engage on the individual action plans to assess a “magic number” for local resources and those from elsewhere that can be utilized while still respecting the effective supervision principles. 

The Central Bank will also be influenced by the evolving regulatory environment for fund management companies at an EU level as seen in the recent ESMA AIFMD consultation. Weighing local substance requirements against the continued use of globally dispersed delegates and resources is challenging. This concept initially bubbled up in ESMA’s 2017 Brexit opinion and has remained a key consideration at ESMA ever since. As we enter 2021, it is clear that location, location, location will become increasingly important to all global asset managers operating within the EU. 

Brown Brothers Harriman & Co. (“BBH”) may be used as a generic term to reference the company as a whole and/or its various subsidiaries generally. This material and any products or services may be issued or provided in multiple jurisdictions by duly authorized and regulated subsidiaries.This material is for general information and reference purposes only and does not constitute legal, tax or investment advice and is not intended as an offer to sell, or a solicitation to buy securities, services or investment products. Any reference to tax matters is not intended to be used, and may not be used, for purposes of avoiding penalties under the U.S. Internal Revenue Code, or other applicable tax regimes, or for promotion, marketing or recommendation to third parties. All information has been obtained from sources believed to be reliable, but accuracy is not guaranteed, and reliance should not be placed on the information presented. This material may not be reproduced, copied or transmitted, or any of the content disclosed to third parties, without the permission of BBH. All trademarks and service marks included are the property of BBH or their respective owners.© Brown Brothers Harriman & Co. 2020. All rights reserved.

This browser is not fully supported by our public website and may not display or function as expected for this reason. Please note, the Infuse Portal and BBH client applications fully support the IE 11 browser.

Important Information for Non-U.S. Residents

You are required to read the following important information, which, in conjunction with the Terms and Conditions, governs your use of this website. Your use of this website and its contents constitute your acceptance of this information and those Terms and Conditions. If you do not agree with this information and the Terms and Conditions, you should immediately cease use of this website. The contents of this website have not been prepared for the benefit of investors outside of the United States. This website is not intended as a solicitation of the purchase or sale of any security or other financial instrument or any investment management services for any investor who resides in a jurisdiction other than the United States1. As a general matter, Brown Brothers Harriman & Co. and its subsidiaries (“BBH”) is not licensed or registered to solicit prospective investors and offer investment advisory services in jurisdictions outside of the United States. The information on this website is not intended to be distributed to, directed at or used by any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Persons in respect of whom such prohibitions apply must not access the website.  Under certain circumstances, BBH may provide services to investors located outside of the United States in accordance with applicable law. The conditions under which such services may be provided will be analyzed on a case-by-case basis by BBH. BBH will only accept investors from such jurisdictions or countries where it has made a determination that such an arrangement or relationship is permissible under the laws of that jurisdiction or country. The existence of this website is not intended to be a substitute for the type of analysis described above and is not intended as a solicitation of or recommendation to any prospective investor, including those located outside of the United States. Certain BBH products or services may not be available in certain jurisdictions. By choosing to access this website from any location other than the United States, you accept full responsibility for compliance with all local laws. The website contains content that has been obtained from sources that BBH believes to be reliable as of the date presented; however, BBH cannot guarantee the accuracy of such content, assure its completeness, or warrant that such information will not be changed. The content contained herein is current as of the date of issuance and is subject to change without notice. The website’s content does not constitute investment advice and should not be used as the basis for any investment decision. There is no guarantee that any investment objectives, expectations, targets described in this website or the  performance or profitability of any investment will be achieved. You understand that investing in securities and other financial instruments involves risks that may affect the value of the securities and may result in losses, including the potential loss of the principal invested, and you assume and are able to bear all such risks.  In no event shall BBH or any other affiliated party be liable for any direct, incidental, special, consequential, indirect, lost profits, loss of business or data, or punitive damages arising out of your use of this website. By clicking accept, you confirm that you accept  to the above Important Information along with Terms and Conditions.

 
1BBH sponsors UCITS Funds registered in Luxembourg, in certain jurisdictions. For information on those funds, please see bbhluxembourgfunds.com


captcha image

Type in the word seen on the picture

I am a current investor in another jurisdiction